Review: taking Ritalin and Subutex together


Summary

Drug interactions are reported among people who take Ritalin and Subutex together. This review analyzes the effectiveness and drug interactions between Ritalin and Subutex. It is created by eHealthMe based on reports of 41 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Ritalin and Subutex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ritalin

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Ritalin 11,167 users)

Subutex

Subutex has active ingredients of buprenorphine hydrochloride. It is often used in drug dependence. (latest outcomes from Subutex 3,050 users)

On Jul, 23, 2016

41 people who take Ritalin, Subutex are studied.


Number of reports submitted per year:

Ritalin and Subutex drug interactions.

Drug effectiveness over time:

Ritalin:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 75.0% - (3 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Subutex:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Ritalin:
  • female: 75.0% - (3 of 4 people)
  • male: 25.0% - (1 of 4 people)
Subutex:
  • female: 100.0% - (4 of 4 people)
  • male: 100.0% - (4 of 4 people)

Drug effectiveness by age:

Ritalin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (3 of 6 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Subutex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (6 of 6 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • anxiety
  • short-term memory loss
  • sweating - excessive
1 - 6 months:
  • diarrhea
  • dizziness
  • feeling hot and cold
  • tachycardia paroxysmal
  • anxiety
  • asthenia
  • drowsiness
  • fatigue
  • flank pain
  • headache
6 - 12 months:
  • movement - unpredictable or jerky
1 - 2 years:
  • renal atrophy
  • glomerulonephritis
  • pyrexia
  • renal failure acute
2 - 5 years:
  • pyrexia
  • renal atrophy
  • renal failure acute
  • haematuria
  • proteinuria
  • glomerulonephritis
  • anuria
  • chills
5 - 10 years:
  • diarrhea
  • dizziness
  • feeling hot and cold
  • tachycardia paroxysmal
  • drowsiness
  • fatigue
  • flank pain
  • movement - unpredictable or jerky
not specified:
  • pneumonia
  • blood creatinine increased
  • hyperkalaemia
  • diabetes mellitus inadequate control
  • glomerular filtration rate decreased
  • renal atrophy
  • accidental exposure
  • bruise
  • capillaritis
  • listless

Most common drug interactions by gender *:

female:
  • accidental exposure
  • bruise
  • capillaritis
  • fatigue
  • listless
  • menstruation irregular
  • drug abuse
  • maternal exposure during pregnancy
  • abdominal pain upper
  • diarrhea
male:
  • pneumonia
  • renal atrophy
  • blood creatinine increased
  • hyperkalaemia
  • pyrexia
  • renal failure acute
  • anuria
  • chills
  • diabetes mellitus inadequate control
  • glomerular filtration rate decreased

Most common drug interactions by age *:

10-19:
  • hand deformity
  • high blood pressure
  • maternal drugs affecting foetus
  • organ failure
  • substance abuse
  • talipes
20-29:
  • diarrhea
  • dizziness
  • feeling hot and cold
  • tachycardia paroxysmal
  • agitation
  • anxiety
  • drowsiness
  • drug abuse
  • eye movement disorder
  • fatigue
30-39:
  • bruise
  • capillaritis
  • menstruation irregular
  • fatigue
  • drug abuse
  • drug dependence
  • abdominal discomfort
  • anxiety
  • injection site erythema
  • injection site inflammation
40-49:
  • renal atrophy
  • pyrexia
  • renal failure acute
  • anuria
  • chills
  • abdominal pain upper
  • glomerulonephritis
  • haematuria
  • proteinuria
  • asthenia
60+:
  • blood creatinine increased
  • hyperkalaemia
  • diabetes mellitus inadequate control
  • glomerular filtration rate decreased
  • diabetes mellitus
  • general physical health deterioration
  • glomerular filtration rate abnormal
  • glycosylated haemoglobin increased
  • pleural mesothelioma malignant
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ritalin and Subutex?

Can you answer these questions?

More questions for: Ritalin, Subutex

You may be interested in these reviews

More reviews for: Ritalin, Subutex

On eHealthMe, Ritalin (methylphenidate hydrochloride) is often used to treat attention deficit hyperactivity disorder. Subutex (buprenorphine hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.